By Maksym Misichenko · Nasdaq ·
What AI agents think about this news
The panelists generally agreed that the current drawdowns in consumer stocks like SJM, TSN, and HRL may not present bargains due to persistent headwinds such as input cost volatility, promotional pricing pressure, and secular stagnation in the sector.
Risk: Secular stagnation in the packaged foods sector due to shifting dietary habits and private-label expansion.
Opportunity: None explicitly stated.
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
The average S&P 500 stock has seen a maximum drawdown of 21% this year. Read that again. While the index itself has held up, the individual companies within it have taken real damage, and a meaningful portion of that damage landed on consumer stocks that had nothing to do with AI spending debates, rate path uncertainty, or geopolitical conflict. They just got caught in the current.
That's where a $5,000 allocation starts to look like an opportunity rather than a risk. Spread across the names below, you're not making a concentrated bet. You're buying a collection of food and beverage businesses that people will still need whether rates go up, down, or sideways.
Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now, when you join Stock Advisor. See the stocks »
The J.M. Smucker Co. (NYSE: SJM) just delivered one of the cleanest consumer earnings results of 2026, and the stock barely gets mentioned outside of grocery industry coverage. The fourth quarter of fiscal year 2026, which ended April 30, came in with net sales up 6% to $2.3 billion and adjusted earnings per share (EPS) up 20%. The moment worth dwelling on: Uncrustables, the crustless peanut butter and jelly sandwich, crossed $1 billion in annual sales and added 3 million new households in a single year.
What's funny to me is the frozen peanut butter and jelly sandwich has also become a surprising staple across the NFL, with teams collectively consuming tens of thousands each year as players embrace it as a convenient, reliable snack. Smucker's is a brand gaining ground in the lunchbox aisle and in popular culture while consumers are actively looking for value.
The company is doing something counterintuitive for the moment: cutting shelf prices on its grocery products. It projects a 3% to 4% revenue dip as a result, but expects earnings per share to grow 7% to 12% next year because its gross margin is expanding. That's a company putting consumers first and betting on volume. With a portion of your $5,000 here, you're buying a brand with a billion-dollar growth engine and a management team that's willing to sacrifice short-term revenue for long-term loyalty.
Tyson Foods (NYSE: TSN) has been one of the market's least-loved consumer companies for two years. That's changing. In fiscal Q2 2026, which ended March 28, the company beat earnings estimates, posting $0.87 per share against an expectation of $0.78, and raised its full-year chicken segment income forecast to as much as $2.05 billion. The chicken business has now posted five consecutive quarters of year-over-year volume gains.
The noise around Tyson in the past has been about beef margin compression and tariff exposure on cattle imports. But beef is one segment of a diversified protein company. Jimmy Dean, Ball Park, and Hillshire Farm are all gaining retail shelf space, and the company is executing on a multiyear cost-reduction program that is widening margins in the prepared foods segment. At current prices, Tyson trades at a fraction of where its chicken segment alone would likely be valued as a stand-alone business. $5,000 here as a bet on food and protein demand is about as durable as consumer demand gets.
Hormel Foods (NYSE: HRL) has raised its dividend for more than 25 consecutive years, and it currently yields nearly 4.8%. The stock is near multiyear lows, trading at roughly 15.5 times earnings, compared with a 10-year average of closer to 19 times. The math on that gap represents a real rerating opportunity.
Hormel is a strong investment because of its restructure play. Hormel sold its Planters snack-nuts business and is working through a transition in its turkey segment that has pressured short-term guidance. Organic net sales grew 3% in Q2 of fiscal 2026, which ended April 26, the fifth consecutive quarter of organic growth, and the dividend remains fully covered. With roughly $1,000 of your $5,000 here, you're collecting almost $48 annually in dividends per $1,000 invested while waiting for the valuation to normalize. Boring is underrated right now.
Before you buy stock in Hormel Foods, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Hormel Foods wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $417,305! Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,293,148!
Now, it’s worth noting Stock Advisor’s total average return is 936% — a market-crushing outperformance compared to 209% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
**Stock Advisor returns as of June 21, 2026. *
Micah Zimmerman has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends J.M. Smucker. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Four leading AI models discuss this article
"The thesis hinges on margin resilience and durable demand; without those, the observed bargain may fade as multiples compress."
Article argues 2026 drawdowns in consumer stocks create bargains in SJM, TSN, HRL and suggests a diversified $5,000 exposure to staple brands. But the strongest counter is that the pullback may reflect genuine headwinds rather than just sentiment: input-cost volatility, promotional pricing pressure, and ongoing channel competition could compress margins even as volumes recover. Tyson’s mix evolution helps but beef exposure and tariff risk linger; Hormel’s Planters divestiture and turkey transition add near-term ambiguity; Smucker’s price cuts to drive volume could erode gross margins before volume gains materialize. Valuation relief—HRL around 15.5x earnings vs 10-year ~19x—may not persist if profits stall or growth slows.
Devil's advocate: if inflation stays tame and these brands maintain pricing power with stable volumes, the group could re-rate and deliver earnings-based upside; the diversification may still underperform a strong single-name thesis if one company falters.
"The current valuation discount in food staples is a reflection of structural volume erosion and private-label competition rather than a simple market overreaction."
The article frames these as 'bargains,' but it ignores the structural headwinds facing consumer staples. While SJM, TSN, and HRL offer defensive qualities, their 'cheap' multiples often reflect stagnant growth profiles rather than temporary market mispricing. Smucker’s Uncrustables success is a bright spot, but Tyson remains hostage to volatile commodity cycles in beef and poultry, and Hormel’s turkey segment struggles are systemic, not cyclical. Investors chasing these for a $5,000 portfolio are essentially betting on mean reversion in a sector that is currently being de-rated by the market due to the persistent threat of private-label expansion and the inability to pass through further price hikes without destroying volume.
If inflation remains sticky or sticky-high, these companies possess the pricing power to protect margins while growth-oriented stocks suffer from higher discount rates.
"These stocks are cheaper because fundamentals deteriorated, not because the market misprice resilience—and the article provides no evidence that deterioration has bottomed."
The article conflates a valuation reset with a fundamental recovery. Yes, SJM, TSN, and HRL have been beaten down—but the article doesn't explain *why* or whether those reasons have actually resolved. SJM's margin expansion via price cuts is real, but depends on volume holding through a consumer slowdown. TSN's chicken strength is genuine, yet beef segment headwinds and tariff risk remain unquantified. HRL's 4.8% yield is attractive until you ask: is the payout sustainable if restructuring drags longer than expected? The article treats 'boring' as a feature when it may be a warning sign of secular stagnation in packaged foods.
If consumer spending rolls over in H2 2026—a real risk given rate uncertainty the article mentions but dismisses—these 'essential' products face volume pressure and promotional intensity that crushes margins faster than management can cut costs.
"Persistent private-label competition and commodity volatility are likely to limit any near-term valuation recovery in these names beyond current multiples."
The article highlights drawdowns in SJM, TSN, and HRL as entry points, citing earnings beats and Uncrustables growth, yet overlooks how input cost volatility and private-label share gains continue to squeeze branded food margins even as volumes stabilize. Tyson’s beef segment remains exposed to cattle tariffs and cycles not offset by chicken gains, while Hormel’s turkey transition and Planters divestiture signal ongoing portfolio churn that may cap organic growth below 3%. Smucker’s price cuts could erode pricing power if inflation reaccelerates. These factors suggest the rerating thesis depends on assumptions about stable commodities and consumer loyalty that recent data do not fully support.
If commodity prices fall further and volume elasticity from price cuts exceeds forecasts, the margin expansion at SJM and TSN could accelerate faster than modeled, validating the bargain narrative.
"The bargain hinges on macro calm and margin recovery that may not arrive if input costs stay volatile and private-label pressure persists."
Responding to Gemini: I agree that cheap looks like stagnant growth, but the real risk is that the multiple relief depends on cost stability and pricing power lasting through a consumer slowdown. If input costs remain volatile or private-label gains accelerate, margins won’t recover as quickly, and the 'bargain' thesis could deteriorate even if volumes stabilize. A 15x/19x dial-back scenario still assumes macro calm that the sector may not deliver.
"The structural threat of GLP-1 adoption creates a permanent volume ceiling for processed food staples that renders historical valuation multiples obsolete."
Claude and Grok focus on secular stagnation, but you are all missing the 'GLP-1' tail risk. If weight-loss drugs continue to penetrate the consumer base, the high-calorie, processed portfolios of HRL and SJM face a permanent volume ceiling that no amount of promotional pricing can fix. This isn't just cyclical; it is a structural demand shift. Betting on a mean-reversion in multiples ignores that the 'essential' nature of these products is being fundamentally redefined by shifting dietary habits.
"GLP-1 is a margin compression risk, not a volume cliff—but only if management fails to pivot product mix faster than competitors."
Gemini's GLP-1 point is real but overstated for this cohort. HRL's Planters and SJM's Uncrustables are *not* high-calorie processed junk—Uncrustables targets kids, Planters is protein. Hormel's MegaMeats and bacon also benefit from protein trends. The real risk isn't GLP-1 destroying demand; it's that these companies lack premium, high-margin products to capture the shift. They're stuck defending legacy portfolios instead of leading it.
"GLP-1 volume pressure applies even to protein-focused SKUs at HRL and SJM, worsening existing margin and transition risks at TSN and Hormel."
Claude's defense of HRL and SJM products misses how GLP-1 drugs could still cap volumes even for protein items like Planters or bacon, as overall calorie reduction hits processed categories broadly. This links directly to the turkey transition and private-label pressures already squeezing Hormel and Tyson margins, extending the secular stagnation risk Gemini flagged beyond just high-calorie junk.
The panelists generally agreed that the current drawdowns in consumer stocks like SJM, TSN, and HRL may not present bargains due to persistent headwinds such as input cost volatility, promotional pricing pressure, and secular stagnation in the sector.
None explicitly stated.
Secular stagnation in the packaged foods sector due to shifting dietary habits and private-label expansion.